Home›Companies›Healthcare›Emerging Therapy Solutions

Emerging Therapy Solutions, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 26, 2024·Suggest an edit

About Emerging Therapy Solutions

Emerging Therapy Solutions is a private company based in Bloomington, Minnesota. It has reported $24,287,128 raised in seven offerings on Form D since January 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 11, 2024Mar 26, 2024$5,000,000fully sold5$1.0MEquityRule 506(b)Form D ↗
Dec 14, 2022Dec 20, 2022$3,000,000target not set5$600KEquityRule 506(b)Form D ↗
Jun 1, 2021Jun 7, 2021$6,004,725target not set5$1.2MEquityRule 506(b)Form D ↗
Jan 27, 2021Feb 11, 2021$1,000,000fully sold5$200KConvertible Promissory NotesRule 506(b)Form D ↗
Feb 5, 2020Feb 18, 2020$2,982,403fully sold5$596KEquityRule 506(b)Form D ↗
May 10, 2019May 22, 2019$1,000,000fully sold1$1.0MEquityRule 506(b)Form D ↗
Dec 19, 2018Jan 4, 2019$5,300,000target not set4$1.3MEquityRule 506(b)Form D ↗
Total, seven offerings$24,287,128

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Emerging Therapy Solutions's Form D filed Mar 26, 2024.

RN
Ravi Nalliah
Director
JM
J. Mackowski
Director
NS
Nathan Schmidt
Chief Financial and Administrative Officer
LK
Larry Kocot
Director
KR
Kevin Roche
Executive officer and director
MB
Mike Burke
Director
GC
Gary Curtis
Director
RC
Rob Capone
Director
AH
Ashley Hume
Executive officer

Earlier filings also listed Ravi Naliah (director, last listed Dec 2022), David McLean (ceo and director, last listed Dec 2022), Steve Lefar (director, last listed Jun 2021), Jeanette Welsh (director, last listed Jun 2021) and Matt Mackowski (director, last listed May 2019).

Sources

  1. SECEmerging Therapy Solutions, Inc. filing history